Endokrynologia PolskaAgedHumansNeuroendocrine TumorsOctreotidePancreatic Neoplasms
Efficacy and safety of radioligand therapy in a 76-year-old patient with metastatic grade 2 pancreatic neuroendocrine tumor.
Anna Zemczak, Olgierd Chrabański, Beata Kos-Kudła
Published: 202510.5603/ep.109778
Abstract
Not required for Clinical Vignette.